The Lancet Healthy Longevity
Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2
Randomised trial in 332,438 peopleInfluenza
3 results